Alpha Capital Group discount code
Alpha Capital Group has no public discount code live right now. Anything you see advertised elsewhere is usually an expired promotion. We update this page the day a code goes live.
What the Alpha Capital Group code actually saves you
With no public code live, $99 is what a Alpha Capital Group evaluation costs today — and two attempts costs $198. That matters when you compare against firms running permanent 80–90% promotions, where three attempts can still land under the price of one full-price evaluation elsewhere. The honest framing: at Alpha Capital Group you are paying for something other than a cheap entry, so make sure that something — payout evidence, drawdown model, platform — is what you actually need.
What you actually pay
- Entry price
- $99
- Max allocation
- $400k
- Profit split
- 90%
- Evaluation
- 1-step
- Payouts
- Bi-weekly
- Consistency rule
- None
Before you buy
The real cost of ownership at Alpha Capital Group
Entry around $99 places Alpha in the middle of the market — well above Funding Pips, well below FTMO. Discount codes are rarer here than at competitors, so budget the list price.
No recurring fees on funded accounts. The cost of ownership is simply the number of attempts.
Is a discounted Alpha Capital Group account worth buying?
A code only helps if the account behind it suits how you trade. Alpha Capital Group runs a none consistency setup with bi-weekly payouts and a first withdrawal around day 14, on a payout-evidence score of 83/100.
Buy it if
- · UK and EU traders who want a domestic corporate counterparty
- · Risk-averse traders who prioritise rule stability
- · Forex traders who want one-step funding with static drawdown
Skip it if
- · Bargain hunters waiting for 80% off promotions
- · Futures traders
- · Traders chasing the very highest split
Where to check next
A cheap evaluation is only cheap if the firm pays. Check the Alpha Capital Group payout evidence and the full Alpha Capital Group review first, or compare against the cheapest challenges overall.